| DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR | None | ||
| 250MG;12.5MG, 75MG, 50MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| VIEKIRA PAK is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV): • genotype 1b without cirrhosis or with compensated cirrhosis • genotype 1a without cirrhosis or with compensated cirrhosis for use in combination with ribavirin. | |||
|
Yes
| |||
| VIEKIRA PAK (COPACKAGED) | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||
| ****-********* ****** *** **** ******* | *********** ********* * ****** ******** ********** | ******* *** ******** *** | ******* *** ******** *** | ****-********* ****** *** **** ******* | *********** ********* * ****** ******** ********** | ******* *** ******** *** | ******* *** ******** *** | ***** ************ | ****-***** ********* | ****-***** ********* | ************ *** ******* *** ******** *** | ****-********* ****** *** **** ******* | ************ ** *************** ********** ********* | ************ ** *************** ********** ********* | ****** *** ********* **************** | ****** *** ********* **************** | ********* ** * ************** | ***** ********** *************** ************ | ***** ************** ****** **** | ***** ************** ****** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|